Cite

HARVARD Citation

    Sartor, O. et al. (2018). Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program. Oncologist. pp. 193-202. [Online]. 
  
Back to record